178 related articles for article (PubMed ID: 23394526)
1. Neuroglial roots of neurodegenerative diseases: therapeutic potential of palmitoylethanolamide in models of Alzheimer's disease.
Scuderi C; Steardo L
CNS Neurol Disord Drug Targets; 2013 Feb; 12(1):62-9. PubMed ID: 23394526
[TBL] [Abstract][Full Text] [Related]
2. Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α.
Scuderi C; Valenza M; Stecca C; Esposito G; Carratù MR; Steardo L
J Neuroinflammation; 2012 Mar; 9():49. PubMed ID: 22405189
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation.
Paterniti I; Cordaro M; Campolo M; Siracusa R; Cornelius C; Navarra M; Cuzzocrea S; Esposito E
CNS Neurol Disord Drug Targets; 2014; 13(9):1530-41. PubMed ID: 25106636
[TBL] [Abstract][Full Text] [Related]
4. Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice.
Tomasini MC; Borelli AC; Beggiato S; Ferraro L; Cassano T; Tanganelli S; Antonelli T
J Alzheimers Dis; 2015; 46(2):407-21. PubMed ID: 25765918
[TBL] [Abstract][Full Text] [Related]
5. Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation.
Esposito G; Capoccia E; Turco F; Palumbo I; Lu J; Steardo A; Cuomo R; Sarnelli G; Steardo L
Gut; 2014 Aug; 63(8):1300-12. PubMed ID: 24082036
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPARα) and its lipid ligands.
Fidaleo M; Fanelli F; Ceru MP; Moreno S
Curr Med Chem; 2014; 21(24):2803-21. PubMed ID: 24606520
[TBL] [Abstract][Full Text] [Related]
7. Palmitoylethanolamide reduces formalin-induced neuropathic-like behaviour through spinal glial/microglial phenotypical changes in mice.
Luongo L; Guida F; Boccella S; Bellini G; Gatta L; Rossi F; de Novellis V; Maione S
CNS Neurol Disord Drug Targets; 2013 Feb; 12(1):45-54. PubMed ID: 23394524
[TBL] [Abstract][Full Text] [Related]
8. Palmitoylethanolamide in CNS health and disease.
Mattace Raso G; Russo R; Calignano A; Meli R
Pharmacol Res; 2014 Aug; 86():32-41. PubMed ID: 24844438
[TBL] [Abstract][Full Text] [Related]
9. Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.
Skaper SD; Facci L; Giusti P
Mol Neurobiol; 2013 Oct; 48(2):340-52. PubMed ID: 23813098
[TBL] [Abstract][Full Text] [Related]
10. Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer's disease.
Scuderi C; Stecca C; Valenza M; Ratano P; Bronzuoli MR; Bartoli S; Steardo L; Pompili E; Fumagalli L; Campolongo P; Steardo L
Cell Death Dis; 2014 Sep; 5(9):e1419. PubMed ID: 25210802
[TBL] [Abstract][Full Text] [Related]
11. Palmitoylethanolamide protects against the amyloid-β25-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease.
D'Agostino G; Russo R; Avagliano C; Cristiano C; Meli R; Calignano A
Neuropsychopharmacology; 2012 Jun; 37(7):1784-92. PubMed ID: 22414817
[TBL] [Abstract][Full Text] [Related]
12.
Li M; Wang D; Bi W; Jiang ZE; Piao R; Yu H
J Pharmacol Exp Ther; 2019 Apr; 369(1):163-172. PubMed ID: 30635472
[No Abstract] [Full Text] [Related]
13. Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects.
Scuderi C; Bronzuoli MR; Facchinetti R; Pace L; Ferraro L; Broad KD; Serviddio G; Bellanti F; Palombelli G; Carpinelli G; Canese R; Gaetani S; Steardo L; Steardo L; Cassano T
Transl Psychiatry; 2018 Jan; 8(1):32. PubMed ID: 29382825
[TBL] [Abstract][Full Text] [Related]
14. Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-α.
Koch M; Kreutz S; Böttger C; Benz A; Maronde E; Ghadban C; Korf HW; Dehghani F
Neurotox Res; 2011 Feb; 19(2):330-40. PubMed ID: 20221904
[TBL] [Abstract][Full Text] [Related]
15. Palmitoylethanolamide Blunts Amyloid-β42-Induced Astrocyte Activation and Improves Neuronal Survival in Primary Mouse Cortical Astrocyte-Neuron Co-Cultures.
Beggiato S; Borelli AC; Ferraro L; Tanganelli S; Antonelli T; Tomasini MC
J Alzheimers Dis; 2018; 61(1):389-399. PubMed ID: 29154284
[TBL] [Abstract][Full Text] [Related]
16. Palmitoylethanolamide Regulates Production of Pro-Angiogenic Mediators in a Model of β Amyloid-Induced Astrogliosis In Vitro.
Cipriano M; Esposito G; Negro L; Capoccia E; Sarnelli G; Scuderi C; De Filippis D; Steardo L; Iuvone T
CNS Neurol Disord Drug Targets; 2015; 14(7):828-37. PubMed ID: 25801844
[TBL] [Abstract][Full Text] [Related]
17. Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma.
Esposito E; Cuzzocrea S
Mini Rev Med Chem; 2013 Feb; 13(2):237-55. PubMed ID: 22697514
[TBL] [Abstract][Full Text] [Related]
18. Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide.
Scuderi C; Esposito G; Blasio A; Valenza M; Arietti P; Steardo L; Carnuccio R; De Filippis D; Petrosino S; Iuvone T; Di Marzo V; Steardo L
J Cell Mol Med; 2011 Dec; 15(12):2664-74. PubMed ID: 21255263
[TBL] [Abstract][Full Text] [Related]
19. N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution.
Skaper SD; Facci L; Barbierato M; Zusso M; Bruschetta G; Impellizzeri D; Cuzzocrea S; Giusti P
Mol Neurobiol; 2015 Oct; 52(2):1034-42. PubMed ID: 26055231
[TBL] [Abstract][Full Text] [Related]
20. Palmitoylethanolamide prevents neuroinflammation, reduces astrogliosis and preserves recognition and spatial memory following induction of neonatal anoxia-ischemia.
Holubiec MI; Romero JI; Suárez J; Portavella M; Fernández-Espejo E; Blanco E; Galeano P; de Fonseca FR
Psychopharmacology (Berl); 2018 Oct; 235(10):2929-2945. PubMed ID: 30058012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
